Kamal Alrabi

8PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Oncology and carcinogenesis not elsewhere classifiedPoverty, inclusivity and wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2026
Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

|Jul 08, 2025
Clinical Characteristics and Treatment Outcomes of Colorectal Cancer in Jordan, a Resource-Restricted Country.

Hikmat Abdel-Razeq, Maha Barbar, Sarah Abdel-Razeq

|Jan 25, 2025
The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.

Akram Al-Ibraheem, Ahmad Saad Abdlkadir, Nabil Hasasna

|Oct 07, 2024
An Unusual Case of Oligometastases in a Patient with Renal Cell Carcinoma: Insights from 18F-FDG PET/CT.

Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Batool Albalooshi

|Oct 03, 2024
Cancer Care in Resource-Limited Countries: Jordan as an Example.

Hikmat Abdel-Razeq, Akram Al-Ibraheem, Kamal Al-Rabi

|May 11, 2024
FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review.

Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci

Pageof 2

Frequent Collaborators

7 joint publications

Akram Al-Ibraheem

3 joint publications

Asem Mansour

3 joint publications

Hikmat Abdel-Razeq

3 joint publications

Mohammad Makoseh